GlassScriptPhysician profile
Thomas Davenport
NPI 1174583405
$2,832,208.61
in general payments reported to CMS, 2019-2025
30 companies · $2.8M in 2025
The $2.8M reported for 2025 was more than what 99% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,857 · 2020: $609 · 2021: $2,322 · 2022: $3,976 · 2023: $3,157 · 2024: $2,714 · 2025: $2.8M.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $2.8M · Food and Beverage: $4,085 · Grant: $1,381 · Travel and Lodging: $1,350 · Honoraria: $550 · Consulting Fee: $525 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $53.57.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $2,815,500.00 |
| Food and Beverage | $4,084.97 |
| Grant | $1,380.95 |
| Travel and Lodging | $1,349.99 |
| Honoraria | $550.00 |
| Consulting Fee | $525.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $53.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xtant Medical INC | $2,815,500.00 | 2025 | |
| Tela Bio, INC. | $4,385.79 | 2019-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Allergan, INC. | $2,103.95 | 2019-2022 | |
| Abbvie INC. | $1,652.26 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Botox, Strattice Reconstructive Tissue Matrix Bps |
| Davol INC. | $1,568.95 | 2022-2025 | Phasix Mesh |
| Sientra, INC. | $1,156.19 | 2020-2021 | |
| Axogen | $1,146.01 | 2021-2025 | Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Ha+ Nerve Protector |
| Stryker Corporation | $749.99 | 2022 | |
| Smith+Nephew, INC. | $719.97 | 2019-2025 | Pico, Renasys Touch, Collagenase Santyl |
| Avita Medical Americas, LLC | $555.92 | 2024 | |
| Motiva USA, LLC | $364.00 | 2025 | |
| Polarityte, INC. | $341.46 | 2021 | |
| Mentor Worldwide LLC | $326.98 | 2022-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Becton, Dickinson and Company | $275.00 | 2023 | |
| Lifenet Health | $220.63 | 2023-2024 | Theragenesis Wound Matrix |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tepha INC | $195.18 | 2019 | |
| Medline Industries LP | $173.37 | 2019 | |
| Deroyal Industries, INC. | $161.27 | 2024-2025 | Lumitech Incisional Wound Dressing |
| Sanara Medtech INC. | $143.54 | 2020 | |
| Musculoskeletal Transplant Foundation INC. | $96.65 | 2025 | |
| Convatec INC. | $72.56 | 2021-2024 | |
| Acera Surgical, INC. | $63.32 | 2025 | Restrata Wound Matrix |
| Polynovo North America LLC | $42.82 | 2025 | Novosorb Btm |
| Mimedx Group, INC. | $41.72 | 2024 | |
| Integra Lifesciences Corporation | $35.91 | 2020-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Bioventus LLC | $33.24 | 2022 | |
| Kci USA, INC. | $26.01 | 2022 | |
| Ovik Health, LLC | $20.77 | 2024 | Coflex Tlc |
| Baxter Healthcare | $18.08 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $17.07 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Davenport listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.